Health Status in the Islamic Republic of Iran, Middle East and North Af-rica Countries: Implications for Global Health

  • Hossein MIRZAEI HIV/STI Surveillance Research Center, WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  • Zhaleh ABDI National Institute for Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran
  • Elham AHMADNEZHAD National Institute for Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran
  • Mahshad GOHRIMEHR National Institute for Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran
  • Elham ABDALMALEKI National Institute for Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran
  • Rezvaneh ALVANDI National Institute for Health Research (NIHR), Tehran University of Medical Sciences, Tehran, Iran
  • Iraj HARIRCHI School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Keywords: Health status, Non-communicable disease, Iran, Global health, Sustainable development goals

Abstract

Background: The aim of this study was to evaluate the health status of the Iranians following the sustainable development goals’ (SDGs) introduction and the recent health reform implementation in Iran and to compare with those of the Middle East and North Africa region (MENA) and global average.

Methods: This comparative study used secondary data to investigate socio-demographic and health status indicators. The sources included census, population-based surveys and death registries. Global and regional health status indicators were obtained from international databases including WHO, the World Bank and the Institute for Health Metric and Evaluation (IHME).

Results: Life expectancy and human development index improved following the reform implementation. Among causes of death, 74.6% were attributed to non-communicable diseases (NCDs). There was an increasing trend in risk factors for NCDs in Iran, while at the same time neonatal, infant and under-5 mortality rates reduced. Compared to the MENA, Iran has a lower maternal mortality ratio, neonatal, infant, and under-5 mortality rates, and a higher life expectancy. NCDs and road traffic injuries accounted for a larger portion of disability-adjusted life years in Iran compared to the MENA and worldwide.

Conclusion: Actions against communicable diseases and road traffic injuries are required together with continued efforts to address NCDs. Although based on the results, Iran has relatively high rankings, there is a need ‎to develop a roadmap to accelerate achieving global health goals and SDGs targets. 

References

1. Claeson M, Waldman RJ (2000). The evolution of child health programmes in developing countries: from targeting diseases to targeting people. Bull World Health Organ, 78:1234-45.
2. Dye C(2014). After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci, 369(1645):20130426.
3. Arredondo A, Aviles R(2015). Costs and Epidemiological Changes of Chronic Diseases: Implications and Challenges for Health Systems. PLoS ONE, 10(3):e0118611.
4. Pablos-Mendez A, Cavanaugh K, Ly C(2016). The new era of health goals: universal health coverage as a pathway to the Sustainable Development Goals. Health Syst Reform, 2(1):15-17.
5. Asbu EZ, Masri MD, Kaissi A(2017). Health status and health systems financing in the MENA region: roadmap to universal health coverage. Glob Health Res Policy, 2(1):25.
6. Mousavi SM, Sadeghifar J(2016). Universal health coverage in Iran. Lancet Glob Health, 4(5):e305-e6.
7. DeLusignan S, Teasdale S, Little D, et al (2004). Comprehensive computerised primary care records are an essential component of any national health information strategy: report from an international consensus conference. J Innov Health Inform, 12(4):255-64.
8. Naghavi M, Shahraz S, Sepanlou SG, et al (2014). Health transition in Iran toward chronic diseases based on results of Global Burden of Disease 2010. Arch Iran Med, 17(5):321-35.
9. Mboi N, Murty Surbakti I, Trihandini I, et al(2018). On the road to universal health care in Indonesia, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England), 392(10147):581-91.
10. World Health Organization (2011). Monitoring, evaluation and review of national health strategies: a country-led platform for information and accountability. http://www.who.int/healthinfo/country_monitoring_evaluation/1085_IER_131011_web.pdf
11. Lozano R, Wang H, Foreman KJ, et al(2011). Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet, 378(9797):1139-65.
12. Moazzeni MS(2013). Maternal mortality in the Islamic Republic of Iran: on track and in transition. Matern Child Health J, 17(4):577-80.
13. Asadi-Lari M, Sayyari A, Akbari M, Gray D(2004). Public health improvement in Iran—lessons from the last 20 years. Public Health, 118(6):395-402.
14. Jahan S(2017). Human Development Report 2016-Human Development for Everyone. http://hdr.undp.org/sites/default/files/2016_human_development_report.pdf
15. Sharara SL, Kanj SS(2014). War and infectious diseases: challenges of the Syrian civil war. PLoS Pathog, 10(11):e1004438.
16. Dewachi O, Skelton M, Nguyen V-K, et al (2014). Changing therapeutic geographies of the Iraqi and Syrian wars. Lancet, 383(9915):449-57.
17. Forouzanfar MH, Sepanlou SG, Shahraz S, et al(2014). Evaluating causes of death and morbidity in Iran, global burden of diseases, injuries, and risk factors study 2010. Arch Iran Med, 17(5):304-20.
18. Peykari N, Hashemi H, Dinarvand R, et al (2017). National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic. J Diabetes Metab Disord, 16(1):3.
Published
2020-01-07
How to Cite
1.
MIRZAEI H, ABDI Z, AHMADNEZHAD E, GOHRIMEHR M, ABDALMALEKI E, ALVANDI R, HARIRCHI I. Health Status in the Islamic Republic of Iran, Middle East and North Af-rica Countries: Implications for Global Health. Iran J Public Health. 49(1):86-95.
Section
Original Article(s)